Constipation, a common gastrointestinal disorder, often presents a diagnostic and therapeutic challenge. This article aims to elucidate a comprehensive approach to its diagnosis and treatment, enabling physicians to effectively manage this condition.
Diagnosis primarily relies on patients' symptoms, with Rome IV criteria being the standard. However, it's crucial to consider differential diagnoses, including irritable bowel syndrome and opioid-induced constipation. A thorough medical history, physical examination, and, if necessary, additional diagnostic tests such as colonoscopy or transit studies can help rule out secondary causes.
First-line treatment typically involves lifestyle modifications and over-the-counter remedies. Dietary changes, such as increasing fiber and fluid intake, can significantly improve symptoms. Osmotic laxatives are often effective, while stimulant laxatives are reserved for short-term use.
For patients unresponsive to first-line treatment, second-line options include prescription drugs such as lubiprostone, linaclotide, and plecanatide. These agents work by increasing intestinal fluid secretion and accelerating transit, thereby alleviating constipation. However, they may cause side effects like diarrhea and abdominal pain.
In refractory cases, biofeedback therapy or surgical intervention may be considered. Biofeedback is particularly beneficial for patients with dyssynergic defecation. Surgery, while rarely used, is an option for severe cases of slow-transit constipation or rectal prolapse.
Understanding constipation's complexity and adopting a comprehensive approach to its diagnosis and treatment is essential for effective patient management. By tailoring the approach to individual patient needs, physicians can significantly improve their patients' quality of life and reduce the burden of this common condition.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation